Host Genetics Core
宿主遗传学核心
基本信息
- 批准号:8294660
- 负责人:
- 金额:$ 134.08万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2011
- 资助国家:美国
- 起止时间:2011-07-01 至 2013-06-30
- 项目状态:已结题
- 来源:
- 关键词:AIDS/HIV problemAcuteAffectAreaBiometryCandidate Disease GeneCharacteristicsChronicClinicalComputational BiologyContainmentCore FacilityDataData SetDatabasesDisease ProgressionGenesGeneticGenomicsGenotypeGoalsHIV-1HumanImmunologyIndividualInfectionLeadershipLengthMacaca mulattaMolecular BiologyPatientsPredispositionResearch PersonnelSequence AnalysisServicesStrategic PlanningSystemTranslatingVaccine DesignVaccinesVariantViralViruscomputerized data processingdata managementenv Genesgenetic associationtooltransmission processvirus genetics
项目摘要
The overall goal of this CHAVI application is to elucidate viral and host determinants of HIV-1
transmission, persistence, and partial containment in primary human infection, and to translate these findings into rational vaccine design. Core A will support this effort by providing expertise and service in the areas of host genomics and HIV-1 genetics. The Core is comprised of three sections:
1. The Host Genomics Section (under the leadership of Dr. David Goldstein) will elucidate host genetic differences affecting susceptibility to HIV-1 infection and disease progression in early HIV-1 infection. Specific tasks include to (i) identify, validate, and genotype a robust set of tagging SNPs (tSNPs) for 500 high priority human genes to facilitate indirect genetic association studies, (ii) identify putative functional variants among the candidate genes for direct association studies; (iii) develop uniform experimental genotyping approaches; (ivj optimize sequencing primers for direct association studies in the rhesus monkey; (v) investigate all associations at the genetic and functional level; and (vi) establish a robust data management system for clinical as well as host and viral genetic data.
2. The HIV-1 Molecular Biology and Sequencing Section (under the leadership of Dr. Beatrice Hahn), will generate functional HIV-1 env clones and full-length HIV-1 sequences from acutely and chronically infected individuals to elucidate the genetic, biologic, antigenic, and structural characteristics of sexually transmitted virus and the mechanisms underlying this transmission. Specific tasks include to (i) amplify, clone and sequence functional env genes from acute HIV-1 infections; (ii) examine envelopes from acute and chronic HIV-1 infections for phenotypic differences, and (iii) derive full-length HIV-1 sequences from patients with acute HIV-1 infection.
3. The HIV-1 Computational Biology and Biostatistics Section (under the leadership of Bette Korber), will provide interactive automated HIV-1 sequence entry and analysis tools, and establish and maintain an Acute HIV-1 Sequence Database. Specific tasks include to (i) provide an interactive automated HIV-1 sequence data entry system that enables users to identify sequencing errors and contamination as part of their initial data processing; (ii) provide interactive automated tools for baseline analysis/of CHAVI HIV-1 sequences, (iii) make CHAVI HIV-1 sequences publicly available, (iv) build CHAVI investigator interfaces for data entry of immunological data, (v) analyze HIV-1 sequence datasets for acute infection sequence
signatures and (vi) provide statistical support for the CHAVI effort. In Year 02, each of these sections will become an independent core facility (see Strategic Plan), commensurate with the anticipated increase of both host and HIV-1 sequence analysis.
该CHAVI应用程序的总体目标是阐明HIV-1的病毒和宿主决定因素
传播,持久性和部分遏制原发性人类感染,并将这些发现转化为合理的疫苗设计。核心A将通过在宿主基因组学和HIV-1遗传学领域提供专门知识和服务来支持这一努力。核心部分由三个部分组成:
1.宿主基因组学部分(在大卫戈尔茨坦博士的领导下)将阐明宿主遗传差异影响对HIV-1感染的易感性和早期HIV-1感染的疾病进展。具体任务包括:(i)鉴定、验证和基因分型一组用于500个高优先级人类基因的标签SNP(tSNP),以促进间接遗传关联研究;(ii)鉴定候选基因中用于直接关联研究的推定功能变体;(iii)开发统一的实验基因分型方法;(iv)优化用于恒河猴直接关联研究的测序引物;(v)调查遗传和功能水平上的所有关联;以及(vi)建立一个强大的数据管理系统,用于临床以及宿主和病毒遗传数据。
2. HIV-1分子生物学和测序部分(在Beatrice Hahn博士的领导下)将从急性和慢性感染者中产生功能性HIV-1 env克隆和全长HIV-1序列,以阐明性传播病毒的遗传,生物学,抗原和结构特征以及这种传播的机制。具体任务包括:(i)扩增、克隆和测序急性HIV-1感染的功能性env基因;(ii)检查急性和慢性HIV-1感染的包膜表型差异;(iii)从急性HIV-1感染患者中获得全长HIV-1序列。
3. HIV-1计算生物学和生物统计学科(由Bette Korber领导)将提供交互式自动HIV-1序列输入和分析工具,并建立和维持急性HIV-1序列数据库。具体任务包括:㈠提供一个交互式自动HIV-1序列数据输入系统,使用户能够在其初始数据处理过程中识别测序错误和污染;(ii)提供用于CHAVI HIV-1序列基线分析的交互式自动化工具,(iii)公开CHAVI HIV-1序列,(iv)建立CHAVI研究者界面用于免疫学数据的数据输入,(V)分析HIV-1序列数据集的急性感染序列
签名和(六)为CHAVI工作提供统计支持。在2002年,这些部门中的每一个都将成为一个独立的核心设施(见战略计划),与宿主和HIV-1序列分析的预期增长相称。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
NORMAN L LETVIN其他文献
NORMAN L LETVIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('NORMAN L LETVIN', 18)}}的其他基金
RNA EXPRESSION PROFILES OF SIV-SPECIFIC CD8+ T CELLS
SIV 特异性 CD8 T 细胞的 RNA 表达谱
- 批准号:
8357985 - 财政年份:2011
- 资助金额:
$ 134.08万 - 项目类别:
MOSAIC VACCINE-ELICITED IMMUNE RESPONSES IN RHESUS MONKEYS
马赛克疫苗在恒河猴中引起的免疫反应
- 批准号:
8357984 - 财政年份:2011
- 资助金额:
$ 134.08万 - 项目类别:
RECOMBINANT BCG CANDIDATE VACCINE IMMUNOGENICITY STUDY
重组卡介苗候选疫苗免疫原性研究
- 批准号:
8358015 - 财政年份:2011
- 资助金额:
$ 134.08万 - 项目类别:
NONHUMAN PRIMATE CORE CELLULAR IMMUNOLOGY LABORATORY FOR AIDS
非人灵长类艾滋病核心细胞免疫学实验室
- 批准号:
8320840 - 财政年份:2010
- 资助金额:
$ 134.08万 - 项目类别:
RNA EXPRESSION PROFILES OF SIV-SPECIFIC CD8+ T CELLS
SIV 特异性 CD8 T 细胞的 RNA 表达谱
- 批准号:
8172906 - 财政年份:2010
- 资助金额:
$ 134.08万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 134.08万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 134.08万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 134.08万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 134.08万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 134.08万 - 项目类别:
Research Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 134.08万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 134.08万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 134.08万 - 项目类别:
Standard Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 134.08万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 134.08万 - 项目类别:
Operating Grants














{{item.name}}会员




